THE TRANSPORT OF 2 IRON CHELATORS, DESFERRIOXAMINE B AND L1, ACROSS CACO-2 MONOLAYERS

被引:20
作者
HAMILTON, KO [1 ]
STALLIBRASS, L [1 ]
HASSAN, I [1 ]
JIN, Y [1 ]
HALLEUX, C [1 ]
MACKAY, M [1 ]
机构
[1] CIBA GEIGY AG,DIV PHARMACEUT,CH-4002 BASEL,SWITZERLAND
关键词
DESFERRIOXAMINE B; L1; CACO-2; IRON CHELATOR; TRANSPORT;
D O I
10.1111/j.1365-2141.1994.tb04841.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The transport of two iron chelators, desferrioxamine B (DFO) and L1 (1,2-dimethyl-3 hydroxypyridin-4-one) has been studied in vitro using the human adenocarcinoma cell line, Caco-2. The transport of DFO and L1 has also been compared with that of their iron-bound complexes, ferrioxamine (FO) and L1(3)-Fe, respectively. We report an apparent permeability coefficient (P-app) value for DFO of 0.170x10(-7) +/-0.080 cm s(-1). The P-app value of L1 was 1.297 x 10(-5) +/-0.133 cm s(-1). The P-app values of their iron bound complexes FO and L1(3)-Fe are 0.230 x 10(-7) +/-0.065 cm s(-1) and 2.356 x 10(-6) +/-0.365 cm s(-1), respectively. We have shown that the transport of DFO and FO is similar in the Caco-2 cell system. The transport of L1, however, is greatly reduced when complexed to iron. The value for total uptake after 60 min for DFO into the Caco-2 cells was 1.49+/-0.09x10(-3) mmol per filter. The values for total uptake after 60 min for L1 and L1(3)-Fe were 0.37+/-0.03 nmol per filter and 0.04+/-0.01 nmol per filter, respectively. Our results indicate that the poor oral bioavailability of DFO can be attributed to the tow epithelial permeability of the molecule coupled with its size (mol wt 656). In contrast, the oral bioavailability observed with L1 is due to the high lipophilicity and low molecular weight (mol wt 139) of the molecule. We believe that these differences between the two molecules account for LI being better orally absorbed than DFO.
引用
收藏
页码:851 / 857
页数:7
相关论文
共 31 条
[1]   LONG-TERM ASSESSMENT OF EFFICACY AND SAFETY OF L1, AN ORAL IRON CHELATOR, IN TRANSFUSION DEPENDENT THALASSEMIA - INDIAN TRIAL [J].
AGARWAL, MB ;
GUPTE, SS ;
VISWANATHAN, C ;
VASANDANI, D ;
RAMANATHAN, J ;
DESAI, N ;
PUNIYANI, RR ;
CHHABLANI, AT .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) :460-466
[2]  
ALREFAIE FN, 1992, BLOOD, V80, P593
[3]   SERUM NON-TRANSFERRIN-BOUND IRON IN BETA-THALASSEMIA MAJOR PATIENTS TREATED WITH DESFERRIOXAMINE AND L1 [J].
ALREFAIE, FN ;
WICKENS, DG ;
WONKE, B ;
KONTOGHIORGHES, GJ ;
HOFFBRAND, AV .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) :431-436
[4]   CACO-2 CELL-LINE - A SYSTEM FOR STUDYING INTESTINAL IRON TRANSPORT ACROSS EPITHELIAL-CELL MONOLAYERS [J].
ALVAREZHERNANDEZ, X ;
NICHOLS, GM ;
GLASS, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1070 (01) :205-208
[5]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[6]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .1. A MODEL FOR STUDYING THE PASSIVE DIFFUSION OF DRUGS OVER INTESTINAL ABSORPTIVE (CACO-2) CELLS [J].
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (06) :476-482
[7]   DEPLETION OF EXCESSIVE LIVER IRON STORES WITH DESFERRIOXAMINE [J].
COHEN, A ;
MARTIN, M ;
SCHWARTZ, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1984, 58 (02) :369-373
[8]   ABSENCE OF HELA-CELL CONTAMINATION IN 169 CELL LINES DERIVED FROM HUMAN TUMORS [J].
FOGH, J ;
WRIGHT, WC ;
LOVELESS, JD .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 58 (02) :209-214
[9]  
HALLEUX C, 1991, IN VITRO CELL DEV B, V27, P293
[10]  
HERSHKO C, 1973, J LAB CLIN MED, V81, P876